Robust axonal growth and a blunted macrophage response are associated with impaired functional recovery after spinal cord injury in the MRL/MpJ mouse.
Spinal cord injury (SCI) in mammals leads to a robust inflammatory response followed by the formation of a glial and connective tissue scar that comprises a barrier to axonal regeneration. The inbred MRL/MpJ mouse strain exhibits reduced inflammation after peripheral injury and shows true regeneration without tissue scar formation following an ear punch wound. We hypothesized that following SCI, the unique genetic wound healing traits of this strain would result in reduced glial and connective tissue scar formation, increased axonal growth, and improved functional recovery. Adult MRL/MpJ and C57BL/6J mice were subjected to a mid-thoracic spinal contusion and the distribution of axon profiles and selected cellular and extracellular matrix components was compared at 1, 2, 4 and 6 weeks post-injury. Recovery of hind-limb locomotor function was assessed over the same time period. The MRL/MpJ mice exhibited robust axon growth within the lesion, beginning at 4 weeks post-injury. This growth was accompanied by reduced macrophage staining at 1, 2, 4 and 6 weeks post-injury, decreased chondroitin sulfate proteoglycan staining at 1-2 weeks and increased laminin staining throughout the lesion at 2-6 weeks post-injury. Paradoxically, the extent of locomotor recovery was impaired in the MRL/MpJ mice. Close examination of the chronic lesion site revealed evidence of ongoing degeneration both within and surrounding the lesion site. Thus, the regenerative genetic wound healing traits of the MRL/MpJ mice contribute to the evolution of a lesion environment that supports enhanced axon growth after SCI. However, this response occurs at the expense of meaningful functional recovery.
Kostyk
S K
SK
Department of Neurology, The Ohio State University Medical Center, Columbus, OH 43210, USA.
Popovich
P G
PG
Stokes
B T
BT
Wei
P
P
Jakeman
L B
LB
D000818:Animals; D001253:Astrocytes / Q000473:pathology; D001369:Axons / Q000473:pathology / Q000502:physiology* / Q000648:ultrastructure; D001522:Behavior, Animal; D039481:CD11b Antigen / Q000378:metabolism; D015740:Calcitonin Gene-Related Peptide / Q000378:metabolism; D004195:Disease Models, Animal; D005260:Female; D005911:Gliosis / Q000209:etiology; D008124:Locomotion / Q000502:physiology; D008264:Macrophages / Q000502:physiology*; D051379:Mice; D008810:Mice, Inbred C57BL; D019463:Mice, Inbred MRL lpr; D046529:Microscopy, Electron, Transmission / Q000379:methods; D016900:Neurofilament Proteins / Q000378:metabolism; D009474:Neurons / Q000473:pathology / Q000648:ultrastructure; D020127:Recovery of Function / Q000502:physiology*; D013119:Spinal Cord Injuries / Q000473:pathology* / Q000503:physiopathology*; D013997:Time Factors
D039481:CD11b Antigen; D016900:Neurofilament Proteins; D015740:Calcitonin Gene-Related Peptide
J Neurotrauma. 2008 Mar;25(3):196-204
18352833
J Neurosci. 1999 Oct 1;19(19):8182-98
10493720
Proc Natl Acad Sci U S A. 1998 Sep 29;95(20):11792-7
9751744
Mamm Genome. 2001 Jan;12(1):52-9
11178744
J Neurosci. 2008 Jul 9;28(28):7231-43
18614693
Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1686-95
18385092
J Neurotrauma. 2000 Apr;17(4):299-319
10776914
Curr Pharm Des. 2005;11(10):1223-36
15853679
Exp Neurol. 1989 Jan;103(1):34-40
2912748
J Comp Neurol. 2004 Jul 5;474(4):469-86
15174067
J Neurosci. 2002 Sep 1;22(17):7526-35
12196576
Semin Cell Dev Biol. 2002 Oct;13(5):361-8
12324218
Exp Neurol. 1996 Jun;139(2):244-56
8654527
Heredity (Edinb). 2001 Jun;86(Pt 6):668-74
11595047
FASEB J. 1996 Sep;10(11):1296-302
8836043
Nat Neurosci. 2006 Jun;9(6):843-52
16699509
Eur J Neurosci. 2007 Mar;25(6):1725-42
17432961
J Comp Neurol. 1996 Jul 15;371(1):104-15
8835721
Dev Neurobiol. 2007 Aug;67(9):1148-65
17514713
Exp Neurol. 1987 Mar;95(3):548-70
3817079
J Anat. 2006 Oct;209(4):547-59
17005026
Dev Dyn. 2003 Feb;226(2):295-307
12557207
Wound Repair Regen. 2000 Jul-Aug;8(4):282-91
11013020
Exp Neurol. 2008 Feb;209(2):294-301
17617407
Nat Rev Neurosci. 2008 Jun;9(6):481-93
18490917
J Invest Dermatol. 2007 May;127(5):998-1008
17435785
Annu Rev Cell Dev Biol. 2004;20:725-57
15473858
J Neurosurg. 2003 Sep;99(2 Suppl):188-97
12956462
J Neurosci. 1999 Jul 15;19(14):5810-22
10407022
Nat Med. 2006 Jul;12(7):829-34
16783372
J Neurosci. 2004 Mar 3;24(9):2143-55
14999065
J Comp Neurol. 2003 Nov 17;466(3):422-44
14556298
J Comp Neurol. 2006 Feb 1;494(4):578-94
16374800
Brain. 2006 Dec;129(Pt 12):3249-69
17071951
Philos Trans R Soc Lond B Biol Sci. 2004 May 29;359(1445):745-51
15293801
J Neurobiol. 1990 Oct;21(7):1108-22
2258724
J Comp Neurol. 2003 Aug 4;462(4):431-49
12811811
J Neurosci. 2005 Aug 31;25(35):8066-76
16135764
J Neurotrauma. 1995 Feb;12(1):1-21
7783230
J Neurotrauma. 1992 Fall;9(3):197-217
1474608
J Neurochem. 2007 Apr;101(1):27-40
17241119
J Comp Neurol. 1996 Jul 29;371(3):485-95
8842901
J Comp Neurol. 1997 Jan 20;377(3):443-64
8989657
Neuroscience. 2004;127(4):821-32
15312895
Exp Neurol. 1999 Aug;158(2):351-65
10415142
J Morphol. 1975 Aug;146(4):533-42
1171254
J Comp Neurol. 2003 Jul 21;462(2):223-40
12794745
Exp Neurol. 2001 Jun;169(2):239-54
11358439
J Neurobiol. 2002 Jun 15;51(4):285-301
12150504
Nature. 1997 Dec 18-25;390(6661):680-3
9414159
Exp Neurol. 1995 Nov;136(1):32-43
7589332
Wound Repair Regen. 2006 Jan-Feb;14(1):81-90
16476076
J Neurochem. 2007 Jul;102(1):37-50
17403033
J Neurotrauma. 2006 May;23(5):635-59
16689667
J Neurotrauma. 2002 Oct;19(10):1251-60
12427332
Neurosci Lett. 1988 Jun 17;89(1):1-6
3399135
Clin Immunol Immunopathol. 1998 Jul;88(1):35-45
9683548
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4097-106
16249486
Neuroreport. 2002 Mar 4;13(3):A37-48
11930141
Br J Surg. 1968 Jan;55(1):26-31
5635416
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9830-5
11493713
Exp Neurol. 2008 Feb;209(2):313-20
17927983
J Comp Neurol. 2006 Oct 20;498(6):747-61
16927265
Eur J Neurosci. 1999 Oct;11(10):3648-58
10564372
Dev Dyn. 2003 Feb;226(2):245-56
12557203
J Comp Neurol. 2003 Apr 21;459(1):1-8
12629662
Dev Dyn. 2003 Feb;226(2):377-87
12557216